Table 2.
Clinical–pathologic characteristics of cases deemed “discordant” compared with “concordant” cases.
| Discordant (expected ≤ 25, actual > 25), n = 75 | Concordant (expected ≤ 25, actual ≤ 25), n = 1443 | p value | |
|---|---|---|---|
| Age, mean | 61 years | 59 years | 0.1352 |
| Tumor size, mean | 1.7 cm | 1.8 cm | 0.3404 |
| Nottingham Grade | |||
| Grade I | 18 (24%) | 474 (33%) | 0.1289 |
| Grade II | 56 (75%) | 966 (67%) | |
| Grade III | 1 (1%) | 3 (<1%) | |
| PR status | |||
| Negative | 20 (27%) | 68 (5%) | <0.0001 |
| Positive | 55 (73%) | 1375 (95%) | |
| PR H-score mean | 96 | 178 | <0.0001 |
| ER H-score mean | 260 | 262 | 0.5945 |
| Ki-67 index mean | 16 | 14 | 0.0585 |
| Nodal status | |||
| Negative | 63 (84%) | 1249 (87%) | 0.8535 |
| Positive | 9 (12%) | 171 (12%) | |
| ITC | 1 (1%) | 5 (<1%) | |
| Unknown | 2 (3%) | 18 (1%) | |
ER estrogen receptor, PR progesterone receptor, ITC isolated tumor cell.